Status:
RECRUITING
New Treatment for Nocturnal Enuresis in Children
Lead Sponsor:
Sohag University
Conditions:
Nocturnal Enuresis in Children
Eligibility:
All Genders
6-18 years
Phase:
NA
Brief Summary
The aim of the study is to evaluate the role of sulbutiamine in treatment of monosymptomatic nocturnal enuresis in children by using it alone or as a combination therapy with tricyclic antidepressants...
Eligibility Criteria
Inclusion
- Age : 6 - 18 years old.
- All children diagnosed by Primary monosymptomatic nocturnal enuresis in this age group.
Exclusion
- Secondary nocturnal enuresis (child who has been continent for at least 6 months before the onset of bedwetting ).
- congenital anomalies (Posterior urethral valve , ectopic ureter , ectopia vesica ,…)
- history of previous lower urinary tract surgery (Multiple hypospadias surgeries ,…, )
- neurogenic bladder (as underactive bladder ).and urge incontinence.
- presence of post-void residual urine greater than 20% of functional bladder capacity.
- history or evidence of disorders in other organs such as (cardiovascular system disease), liver , psychological problems , evident allergic reaction to both medication.
Key Trial Info
Start Date :
March 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 1 2024
Estimated Enrollment :
450 Patients enrolled
Trial Details
Trial ID
NCT06497647
Start Date
March 1 2024
End Date
November 1 2024
Last Update
July 12 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sohag Faculty of Medecine
Sohag, Egypt